Article
MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Clinical radiology - 1 Apr 2024
Qu J, Zhang T, Zhang X, Zhang W, Li Y, Gong Q, Yao L, Lui S
Abstract excerpt
AIM: To identify clinical and magnetic resonance imaging (MRI) radiomics predictors specialised for intracranial progression (IP) after first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment in non-small-cell lung cancer (NSCLC) patients with brain metastases (BMs). MATERIALS AND METHODS: Seventy EGFR-mutated NSCLC patients with a total of 212 BMs who received first-line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.